Morgan Stanley Maintains Overweight on Sempra, Lowers Price Target to $104

Benzinga · 1d ago
Morgan Stanley analyst David Arcaro maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $108 to $104.